A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma

MLA

Jing Xiang, et al. “A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma.” Cells, vol. 11, no. 7, Mar. 2022, p. 1173. EBSCOhost, https://doi.org/10.3390/cells11071173.

APA

Jing Xiang, Lin Ma, Zheng Gu, Hongjun Jin, Hongbin Zhai, Jianfei Tong, Tianjiao Liang, Juan Li, Qiushi Ren, & Qi Liu. (2022). A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma. Cells, 11(7), 1173. https://doi.org/10.3390/cells11071173

Chicago

Jing Xiang, Lin Ma, Zheng Gu, Hongjun Jin, Hongbin Zhai, Jianfei Tong, Tianjiao Liang, Juan Li, Qiushi Ren, and Qi Liu. 2022. “A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma.” Cells 11 (7): 1173. doi:10.3390/cells11071173.